Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Corrado Pelaia, Anna Ferrante Bannera, Fioramante Lello Rotundo, Francesco Giuseppe Tropea, Giuseppe Armentaro, Angelantonio Maglio, Angela Sciacqua, Alessandro Vatrella & Girolamo Pelaia. (2023) Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 995-1002.
Read now
Read now
Antonio Molino, Giovanna Calabrese & Mauro Maniscalco. (2018) Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol. Patient Preference and Adherence 12, pages 993-1001.
Read now
Read now
Nooreen Shaikh, Malcolm Johnson, David A Hall, Kian Fan Chung, John H Riley, Sally Worsley & Pankaj K Bhavsar. (2017) Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1903-1913.
Read now
Read now
Donald P Tashkin. (2016) A review of nebulized drug delivery in COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2585-2596.
Read now
Read now
Reynold A Panettieri Jr. (2015) Bronchodilators, receptors and cross-talk: Together is better?. Postgraduate Medicine 127:7, pages 771-780.
Read now
Read now
Igor Z Barjaktarevic, Anthony F Arredondo & Christopher B Cooper. (2015) Positioning new pharmacotherapies for COPD. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1427-1442.
Read now
Read now
Anoop Prakash, K Suresh Babu & Jaymin B Morjaria. (2015) Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 111-123.
Read now
Read now
James F Davidson, James F Donohue & Jill A Ohar. (2015) Umeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelines. Expert Opinion on Drug Safety 14:2, pages 317-324.
Read now
Read now
Maria Gabriella Matera, Paola Rogliani, Barbara Rinaldi & Mario Cazzola. (2015) Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease. Expert Review of Clinical Pharmacology 8:1, pages 35-41.
Read now
Read now
Mario Malerba, Jaymin Bhagwanji Morjaria & Alessandro Radaeli. (2014) Differential pharmacology and clinical utility of emerging combination treatments in the management of COPD – role of umeclidinium/vilanterol. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 687-695.
Read now
Read now
Andrea Segreti, Luigino Calzetta, Paola Rogliani & Mario Cazzola. (2014) Umeclidinium for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 8:6, pages 665-671.
Read now
Read now
Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2014) Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 15:7, pages 961-977.
Read now
Read now
Javier de Miguel-Díez & Rodrigo Jiménez-García. (2014) Considerations for new dual-acting bronchodilator treatments for chronic obstructive pulmonary disease. Expert Opinion on Investigational Drugs 23:4, pages 453-456.
Read now
Read now
Articles from other publishers (21)
A. Vezzelli, S. Verzè, L. Morbioli, L. Solazzo, A. Greco, C. Benetti, V. Cenacchi & M. Breda. (2023) Development and validation of a bioanalytical method for the quantification of CHF6550 and its metabolite (CHF6671) in rat plasma and lung homogenate using LC–MS/MS. Journal of Chromatography B 1222, pages 123678.
Crossref
Crossref
N. P. Knyazheskaya, E. Кh. Anaev, A. S. Belevskiy & M. A. Makarova. (2022) Double broncholytic combination of umeclidnium/ vilanterol in COPD therapy: issues of efficacy and safety. Meditsinskiy sovet = Medical Council 16:18, pages 49-54.
Crossref
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
271
299
.
Tao Song, Mingyu Zhang, Jun Wu, Fenghua Chen, Ying Wang, Yujie Ma & Zhijie Dai. (2020) Glioma progression is suppressed by Naringenin and APO2L combination therapy via the activation of apoptosis in vitro and in vivo. Investigational New Drugs 38:6, pages 1743-1754.
Crossref
Crossref
Bartolome R. Celli. (2018) Pharmacological Therapy of COPD. Chest 154:6, pages 1404-1415.
Crossref
Crossref
Zhi-Chao Yang & Ji Ma. (2018) Actein enhances TRAIL effects on suppressing gastric cancer progression by activating p53/Caspase-3 signaling. Biochemical and Biophysical Research Communications 497:4, pages 1177-1183.
Crossref
Crossref
Disala Fernando, Sarah Siederer, Sunita Singh, Ian Schneider, Ashutosh Gupta, Marcy Powell, Duncan Richards, Michelle P. McIntosh, Peter Lambert & Susan Fowles. (2017) Safety, Tolerability and Pharmacokinetics of Single Doses of Oxytocin Administered via an Inhaled Route in Healthy Females: Randomized, Single-blind, Phase 1 Study. EBioMedicine 22, pages 249-255.
Crossref
Crossref
Ying Xu, Jing Li, Qian-Jun Li, Yan-Ling Feng & Feng Pan. (2017) Betulinic acid promotes TRAIL function on liver cancer progression inhibition through p53/Caspase-3 signaling activation. Biomedicine & Pharmacotherapy 88, pages 349-358.
Crossref
Crossref
S. N. Avdeev & Z. R. Aisanov. (2016) MAXIMAL BRONCHODILATION WITH STARTING THERAPY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN INFLUENCE ON THE COURSE OF THE DISEASE. PULMONOLOGIYA 26:5, pages 604-609.
Crossref
Crossref
Li Wang, Chun-juan Zhai, Yao Liu, Yi Liu & Shu-juan Jiang. (2016) Umeclidinium Plus Vilanterol Versus Placebo, Umeclidinium, or Vilanterol Monotherapies for Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials. Clinical Drug Investigation 36:11, pages 865-875.
Crossref
Crossref
S. N. Avdeev, Z. R. Aysanov, A. S. Belevskiy, A. A. Vizel'G. L. Ignatova, N. P. Knyazheskaya, I. V. Leshchenko, S. I. Ovcharenko, V. I. TrofimovE. I. Shmelev. (2016) Perspectives of pharmacological therapy of chronic obstructive pulmonary disease: opportunities of dual bronchodilation and a role of inhaled steroids. Expert Council Consensus. PULMONOLOGIYA 26:1, pages 65-72.
Crossref
Crossref
Jolyon Mitchell. 2016. Developing Drug Products in an Aging Society. Developing Drug Products in an Aging Society
331
382
.
Clive Page & Mario Cazzola. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD
197
212
.
Gustavo J. Rodrigo & Hugo Neffen. (2015) A Systematic Review of the Efficacy and Safety of a Fixed-Dose Combination of Umeclidinium and Vilanterol for the Treatment of COPD. Chest 148:2, pages 397-407.
Crossref
Crossref
Luigino Calzetta, Maria Gabriella Matera & Mario Cazzola. (2015) Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy. European Journal of Pharmacology 761, pages 168-173.
Crossref
Crossref
M. A. Soriano-Ursúa, J. G. Trujillo-Ferrara, J. A. Arias-Montaño & R. Villalobos-Molina. (2015) Insights into a defined secondary binding region on β-adrenoceptors and putative roles in ligand binding and drug design. MedChemComm 6:6, pages 991-1002.
Crossref
Crossref
Dave Singh. (2015) New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives. British Journal of Clinical Pharmacology 79:5, pages 695-708.
Crossref
Crossref
Hannah A. Blair & Emma D. Deeks. (2014) Umeclidinium/Vilanterol: A Review of Its Use as Maintenance Therapy in Adults with Chronic Obstructive Pulmonary Disease. Drugs 75:1, pages 61-74.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Clive P. Page, Paola Rogliani, Francesco Facciolo, Amadeu Gavaldà & Maria Gabriella Matera. (2014) Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi. European Journal of Pharmacology 745, pages 135-143.
Crossref
Crossref
Virginia Norris & Claire Ambery. (2014) Use of Propranolol Blockade to Explore the Pharmacology of GSK961081, a Bi-Functional Bronchodilator, in Healthy Volunteers: Results from Two Randomized Trials. Drugs in R&D 14:4, pages 241-251.
Crossref
Crossref
Adrian Gillissen. (2014) Frischer Wind für COPD-geplagte Lungen. MMW - Fortschritte der Medizin 156:14, pages 68-72.
Crossref
Crossref